Vancouver, British Columbia – (Newsfile Corp. – October 16, 2018) – Benchmark Botanics, Inc. (CSE: BBT; FSE: BBW) (“Benchmark” or the “Company”). Benchmark is pleased to announce that the results of its annual general meeting of shareholders held on October 12, 2018 (the “Meeting”). A total of 76,612,838 common shares were voted at the Meeting, representing 54.14% of the 141,514,642 common shares of the Company that were issued and outstanding as at the record date.

 

All the resolutions put forward by the Company were approved at the Meeting. Manning Elliott LLP, Chartered Professional Accountants, was re-appointed auditor for the ensuing year.  The number of directors for the ensuring year has been set at five. Messrs. Ping (Johnson) Zhang, Claude (Cliff) Stowell, Haifeng Liu, George Dorin and William Ying were elected directors of the Company and will hold office until the next annual meeting of the Company or until their earlier resignation or removal.

 

At a meeting of the board of directors of the Company held immediately following the AGM on October 12, 2018, Mr. George Dorin was elected Chairman of the Board; Mr. William Ying was appointed Chief Executive Officer of the Company; Mr. Haifeng Liu was re-appointed President; Ms. Jin Kuang was re-appointed interim Chief Financial Officer and Corporate Secretary; and Mr. Claude (Cliff) Stowell was re-appointed CEO of Potanicals Green Growers Inc., the wholly owned subsidiary of the Company. Mr. Johnson Zhang, Co-Founder and a Director of the Company, stepped down from his role as Chief Executive Officer.

 

“It has been a great honour to serve as the CEO of Benchmark since its inception. I take great pride in our team’s collective accomplishments and the exceptional progress we have made in such a short period of time,” said Johnson.  “At the dawn of opening of the recreational market in Canada and the numerous overseas opportunities that our Company is positioned to capitalize on, the timing is perfect to bring William on board.”

 

Mr. William Ying brings over 20 years of experience in capital markets and strategic planning to the Company. Since 1996, he has served at various financial institutions including Yorkton Securities, Blackmont Capital, Jordan Capital and Mackie Research Capital. In those roles, William has provided growth investment opportunities to accredited investors globally (institutional, corporate and individual), as well as advised growth-oriented companies in capital raising, M&A, corporate development and other corporate finance activities.  William also participates in the Mentor in Business program at Simon Fraser University (SFU Beedie School of Business) as a mentor to share his business experience with future business leaders.

 

“The Board is confident that, with William’s track record of strong leadership, deep operational knowledge and focus on delivering shareholder value, he will be the perfect compliment to our leadership team and the best candidate to lead our Company into the next phase of our rapid growth,” Johnson continued.

 

“I am truly honored and humbled to be installed at this position and to lead Benchmark at such an important point in the Company’s evolution.  The opportunities that lie ahead are limitless,” said William, “I look forward to working closely with you and lead the company to the next stage. We have a great team in place and I am thrilled to be leading the corporate strategy and vision to drive our venture forward.”

 

“Benchmark is in an exceptional position today thanks to the vision and dedication of Johnson Zhang,” said Haifeng (Leo) Liu. “On behalf of the Board of Directors, our shareholders and our staff, I would like to acknowledge and thank Johnson for his many contributions, tireless efforts and for being the key driver of our growth and success to date.”

 

About Benchmark

 

Benchmark is a publicly traded company based in Vancouver, British Columbia that is positioned to provide financing, partnership and acquisition opportunities to licensed producers and ancillary businesses within the global cannabis industry.

In November 2017, the Company acquired its first subsidiary, Potanicals Green Growers Inc. Potanicals Green Growers possesses a Health Canada license to cultivate and sell cannabis as an Access to Cannabis for Medical Purposes (ACMPR) Licensed Producer. In its first phase of operations, Potanicals is currently cultivating in its 12,700 square foot PHASE I indoor production facility. Benchmark is pursuing additional sites to retrofit for large scale cultivation expansion.

ON BEHALF OF THE BOARD OF

BENCHMARK BOTANICS INC.

George Dorin
Chairman, the Board of Directors

For Further Information

 

Investor Relations

Benchmark Botanics, Inc.

Email: office@bbtinc.ca
Tel: 604-238-0005

www.benchmarkbotanics.com

 

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this release.

 

Forward-Looking Statements

 

This news release contains forward-looking statements pertaining to various risks and uncertainties regarding future events. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the business and future objectives of the Company, including the generation of revenue and sales of cannabis in the adult-use market under the Cannabis Act (Canada). There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including risks related to: (i) the facility and Potanicals’ operations; (ii) adverse market conditions; (iii) the ability of the Company to complete financings in the future; (iv) dependence on suppliers and skilled labour; (v) government regulation and compliance with the ACMPR and the Cannabis Act; (vi) managing and maintaining growth; (vii) unfavourable publicity or consumer perception litigation; and (viii) competition. Actual results could differ materially from those currently anticipated due to a number of factors and risks including the risk factors discussed in this news release and in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com and on the CSE website. These statements speak only as of the date of this news release. Except as required by law, the Company does not intend to update these forward-looking statements.

Vancouver, British Columbia – (Newsfile Corp. – September 27, 2018) – Benchmark Botanics, Inc. (CSE: BBT; FSE: BBW) (“Benchmark” or the “Company”). Benchmark is pleased to announce that the Company has entered into a Trademarks License Agreement (the “Agreement”) with Leidseplein Beheer B.V. (the “Licensor”), a company incorporated under the laws of the Netherlands, in which the Licensor has agreed to grant the Company use of “The Bulldog” trademark in Canada upon the terms and conditions set out in the Agreement.

 

Under the terms of the Agreement, the Company will pay an upfront fee of $120,000 to the Licensor, such amount to be satisfied by the issuance to the Licensor of 214,286 common shares of the Company at a price of $0.56 per share, based on the closing price of the Company’s common shares on the Canadian Securities Exchange on September 19, 2018.

 

As partial consideration for the license granted, the Company will pay to the Licensor royalties based on a percentage of Revenues of the products sold and services provided using “The Bulldog” trademark during the term of the Agreement within 30 days of the end of each quarter of each calendar year.

 

Under the Agreement, Revenue means the arm’s length gross sales received for sales of all licensed products to a third party after deduction of the sales tax and charges for freight, transportation and delivery of licensed products if these costs incurred.

 

Johnson Zhang, Chief Executive Officer of Benchmark, said: “This Agreement represents an important step in the Benchmark journey that both companies will realize benefits from, once the adult-use market in Canada is officially opened in 19 days, on October 17, 2018. With the use of The Bulldog trademarks, we will seek to build one of the most engaging and successful brands and develop leading products in Canada for the adult-use market.

 

With the addition of The Bulldog trademark, which has a long-established history as one of the most well-known coffee shop brands in Amsterdam and beyond, this agreement will assist the Company to position itself in the Canadian adult-use cannabis market. The Company is continuing to make prudent investments and efforts into marketing and branding of our products for the Canadian adult-use cannabis market.”

 

Johnson further commented that “the licensing of The Bulldog trademarks is only the beginning of long-term cooperation with the Licensor. Benchmark will explore other cooperation opportunities with the Licensor in the areas of strains development, branding, and marketing”.

 

About THE BULLDOG

THE BULLDOG is an Amsterdam-based company that owns and operates a chain of cannabis coffee shops, a five star hostel hotel in Amsterdam, locations in Canada and a merchandising line. The Bulldog No. 90 was the first coffee shop in Amsterdam and laid the benchmark for the contemporary coffee shop. What once began in a cellar, has grown into well recognized trade-name in several countries. THE BULLDOG Amsterdam has one of the longest histories of legalized recreational cannabis business with millions of customer visits to its stores every year.

 

 

About Benchmark

 

Benchmark is a publicly traded company based in Vancouver, British Columbia that is positioned to provide financing, partnership and acquisition opportunities to licensed producers and ancillary businesses within the global cannabis industry.

In November 2017, the Company acquired its first subsidiary, Potanicals Green Growers Inc. Potanicals Green Growers possesses a Health Canada license to cultivate and sell cannabis as an Access to Cannabis for Medical Purposes (ACMPR) Licensed Producer. In its first phase of operations, Potanicals is currently cultivating in its 12,700 square foot PHASE I indoor production facility. Benchmark is pursuing additional sites to retrofit for large scale cultivation expansion.

ON BEHALF OF THE BOARD OF

BENCHMARK BOTANICS INC.

/s/ “Ping (Johnson) Zhang”

Ping (Johnson) Zhang

Chief Executive Officer

 

For Further Information

 

Investor Relations

Benchmark Botanics, Inc.

Email: invest@bbtinc.ca
Tel: 604-238-0005

www.benchmarkbotanics.com

 

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this release.

Forward-Looking Statements

This news release contains forward-looking statements pertaining to various risks and uncertainties regarding future events. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the business and future objectives of the Company, including the generation of revenue and sales of cannbis in the adult-use market under the Cannabis Act (Canada). There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including risks related to: (i) the facility and Potanicals’ operations; (ii) adverse market conditions; (iii) the ability of the Company to complete financings in the future; (iv) dependence on suppliers and skilled labour; (v) government regulation and compliance with the ACMPR and the Cannabis Act; (vi) managing and maintaining growth; and (vii) unfavourable publicity or consumer perception litigation; Actual results could differ materially from those currently anticipated due to a number of factors and risks including the risk factors discussed in this news release and in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com and on the CSE website. These statements speak only as of the date of this news release. Except as required by law, the Company does not intend to update these forward-looking statements.

 

 

 

Vancouver, BC, August 28, 2018 – Benchmark Botanics, Inc. (“Benchmark” or the “Company”) (CSE: BBT / US OTC: BHHKF / Frankfurt: BBW.F)

 

Benchmark is pleased to announce that it intends to complete a non-brokered private placement for aggregate gross proceeds of $2,000,000 (the “Private Placement”) with an arm’s-length party who has agreed to subscribe for 2,666,667 units of the Company (the “Units”) at $0.75 per Unit (the “Subscription Price”). The Subscription Price represents a 34% premium to Benchmark’s closing share price on August 20, 2018. Each Unit is comprised of one common share of the Company (each, a “Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant shall be exercisable into one Share at a price of $1.50 for a period of 24 months from the closing date of the Private Placement. All of the Units, Shares and Warrants will be subject to a restricted period of four months and one day from the date of closing of the Private Placement.

The Company intends to use the proceeds from the sale of the Units for general working capital purposes and the costs of setting up the Company’s extraction operations.  The Private Placement is subject to acceptance by the Canadian Securities Exchange.

The securities offered have not been registered under the U.S. Securities Act of 1933, as amended, or applicable state securities laws, and may not be offered or sold to persons in the United States absent registration or an exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Benchmark

Benchmark is a publicly traded company based out of Vancouver, British Columbia positioned to provide financing, partnership opportunities and acquisition offers to licensed producers and ancillary businesses within the global cannabis industry. With the support of our global partners, we acquired our first subsidiary, Potanicals Green Growers Inc. in November 2017. Potanicals is an approved licensed producer of cannabis under the ACMPR that is currently cultivating within a 12,700 square foot production facility.

For more information about Benchmark, refer to the Form 2A Listing Statement available to the public under the Company’s profile on SEDAR at www.sedar.com and the CSE website.

ON BEHALF OF THE BOARD OF

BENCHMARK BOTANICS INC.

/s/ “Ping (Johnson) Zhang”

Ping (Johnson) Zhang

Chief Executive Officer

 

For Further Information

 

Investor Relations

Benchmark Botanics, Inc.

Email: invest@bbtinc.ca
Tel: 604-238-0005

www.benchmarkbotanics.com

 

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this release.

Forward-Looking Statements

This news release contains forward-looking statements pertaining to various risks and uncertainties regarding future events. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the business and future objectives of the Company, the receipt of a License to Sell under the ACMPR and the timing and completion of the Private Placement. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including risks related to: (i) the facility and Potanicals’ operations; (ii) adverse market conditions; (iii) the ability of the Company to complete financings in the future; (iv) dependence on suppliers and skilled labour; (v) government regulation and compliance with the ACMPR; (vi) managing and maintaining growth; (vii) unfavourable publicity or consumer perception litigation; (viii) competition; and (ix) the receipt of a License to Sell under the ACMPR and closing of the Private Placement. The Company is not currently producing medical marijuana. There is a risk that Potanicals’ Producer’s License will not be amended to permit the Company to sell medical marijuana produced at its facility and that the Private Placement may not be completed as planned or at all. Actual results could differ materially from those currently anticipated due to a number of factors and risks including the risk factors discussed in this news release and in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com and on the CSE website. These statements speak only as of the date of this news release. Except as required by law, the Company does not intend to update these forward-looking statements.

Vancouver, British Columbia, Canada – June 15, 2018: Benchmark Botanics Inc. (CSE: BBT / OTC Pink: BBHKF / FSE: BBW) (the “Company” or “Benchmark”) provides an update to the previously announced extension to the contract of purchase and sale for a greenhouse production center located in the lower mainland region of British Columbia. The Company has not made the additional $500,000 non-refundable deposit that was due today in order to extend the completion date from June 1 to July 16, 2018. The Company is seeking to negotiate with the vendor regarding an extension of the completion date, however there is no assurance that it will successfully secure an extension on terms acceptable to the Company or at all and in the interim the original $500,000 non-refundable deposit has been transferred to the vendor.

 

 

About Benchmark

Benchmark Botanics, Inc. is: “Cannabis Redefined”.

 

Benchmark is a publicly traded company based out of Vancouver, British Columbia that is positioned to provide financing, partnership and acquisition opportunities to licensed producers and ancillary businesses within the global cannabis industry.

 

In November 2017, the Company acquired its first subsidiary, Potanicals Green Growers Inc. Potanicals Green Growers possesses a Health Canada license to cultivate cannabis and is an Access to Cannabis for Medical Purposes (ACMPR) Licensed Producer. In its first phase of operations, Potanicals is currently cultivating in its 12,700 square foot PHASE I indoor production facility.

 

For Further Information

 

Investor Relations

Benchmark Botanics, Inc.

Email: invest@bbtinc.ca
Tel: 1-888-221-0915

www.benchmarkbotanics.com

 

Dave Burwell

Vice President

The Howard Group Inc.

Email: dave@howardgroupinc.com

Tel: 403.221-9015

Toll Free: 1-888-221-0915

 

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this release.

 

Forward-Looking Statements

This news release contains forward-looking statements pertaining to various risks and uncertainties regarding future events. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the business and future objectives of the Company, including the timing of completion of the closing of the purchase and sale of the greenhouse facility, if at all. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including related to: (i) the facility and Potanicals’ operations; (ii) adverse market conditions; (iii) the ability of the Company to complete financings in the future; (iv) dependence on suppliers and skilled labour; (v) government regulation and compliance with the ACMPR; (vi) managing and maintaining growth; (vii) unfavourable publicity or consumer perception litigation; (viii) competition; (ix) Benchmark may not be able to secure an extension to the completion date for the contract for the purchase of the greenhouse on terms acceptable to Benchmark or at all; and (x) Benchmark will lose all of its original $500,000 non-refundable deposit if it does not complete the purchase of the greenhouse, face a claim for damages and the agreement to purchase the greenhouse may be terminated by the vendor. There is a risk that Potanicals’ Producer’s License will not be amended to permit the Company to sell medical marijuana produced at its facility. Actual results could differ materially from those currently anticipated due to a number of factors and risks including the risk factors discussed in this news release and in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com and on the CSE website. These statements speak only as of the date of this news release. Except as required by law, the Company does not intend to update these forward-looking statements.

Vancouver, British Columbia, Canada – June 13, 2018: Benchmark Botanics Inc. (CSE: BBT / OTC Pink: BBHKF / FSE: BBW) (the “Company” or “Benchmark”) announces the resignation of Mr. Richard Lee as the Chief Financial Officer of the Company effective June 8, 2018. The Company is currently assessing candidates to fill this vacancy. During the interim, the functions of the Chief Financial Officer will be filled by the Company’s Corporate Controller, Ms. Jin Kuang. Ms. Kuang has previously acted as a CFO of several Reporting Issuers.

 

CEO and Chairman of Benchmark, Mr. Johnson Zhang, comments “On behalf of the entire Board of Directors, I would like to thank Richard Lee for his many contributions to Benchmark and we wish him all the best in his other ventures.

 

About Benchmark

Benchmark Botanics, Inc. is: “Cannabis Redefined”.

 

Benchmark is a publicly traded company based out of Vancouver, British Columbia that is positioned to provide financing, partnership and acquisition opportunities to licensed producers and ancillary businesses within the global cannabis industry.

 

In November 2017, the Company acquired its first subsidiary, Potanicals Green Growers Inc. Potanicals Green Growers possesses a Health Canada license to cultivate cannabis and is an Access to Cannabis for Medical Purposes (ACMPR) Licensed Producer. In its first phase of operations, Potanicals is currently cultivating in its 12,700 square foot PHASE I indoor production facility. Benchmark is pursuing additional sites to retro-fit for large scale cultivation expansion.

 

For Further Information

 

Investor Relations

Benchmark Botanics, Inc.

Email: invest@bbtinc.ca
Tel: 1-888-221-0915

www.benchmarkbotanics.com

 

Dave Burwell

Vice President

The Howard Group Inc.

Email: dave@howardgroupinc.com

Tel: 403.221-9015

Toll Free: 1-888-221-0915

 

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this release.

 

Forward-Looking Statements

This news release contains forward-looking statements pertaining to various risks and uncertainties regarding future events. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the business and future objectives of the Company, including the timing of completion of the closing of the purchase and sale of the greenhouse facility, if at all. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including related to: (i) the facility and Potanicals’ operations; (ii) adverse market conditions; (iii) the ability of the Company to complete financings in the future; (iv) dependence on suppliers and skilled labour; (v) government regulation and compliance with the ACMPR; (vi) managing and maintaining growth; (vii) unfavourable publicity or consumer perception litigation; and (viii) competition. There is a risk that Potanicals’ Producer’s License will not be amended to permit the Company to sell medical marijuana produced at its facility. Actual results could differ materially from those currently anticipated due to a number of factors and risks including the risk factors discussed in this news release and in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com and on the CSE website. These statements speak only as of the date of this news release. Except as required by law, the Company does not intend to update these forward-looking statements.